Apply for funding to coordinate and address tractable challenges in rare diseases and achieve a step change in the mechanistic understanding, diagnosis and therapy of rare diseases.
You must be based at a UK research organisation eligible for MRC funding.
Apply for funding to work with researchers in Japan in the fields of neuroscience, neurodegenerative diseases and dementia. We are looking for internationally competitive, full-scale collaborative and innovative partnerships.
You must be based at a UK research organisation eligible for MRC funding.
Apply for funding to support excellent global health research and strengthen research leadership across sub-Saharan Africa (SSA).
We aim to attract and retain exceptionally talented ‘rising star’ individuals who will lead high quality research on key global health issues pertinent to SSA.
Researchers should be supported by an enthusiastic local research environment and by a UK-based mentor as part of a partnership between the African and UK institutions.
National Science Foundation (NSF), National Institutes of Health (NIH), US Department of Agriculture (USDA), US-Israel Binational Science Foundation (BSF), National Natural Sciences Foundation of China (NSFC)
Agence Nationale de la Recherche (ANR), Canadian Institutes of Health Research (CIHR), Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE), Italian Ministry of Health (MoH)
Apply for funding for the early-stage development of an intervention that seeks to address a UK or global public health challenge.
Any researcher employed by an eligible research organisation, including MRC institutes and units (including those in Gambia and Uganda), can apply for this opportunity.
Department for Environment, Food and Rural Affairs (Defra)
Funding type:
Grant
Total fund:
£6,500,000
Publication date:
8 July 2022
Opening date:
25 July 2022
Closing date:
This is the integrated website of the seven research councils, Research England and Innovate UK.
Let us know if you have feedback or would like to help us test new developments.